Can u help in pharmaceutical research?
Want to make orodispersiblefilm but can't able to choose on which desies or api should I make
orodispersible film drug selection API formulation
best API for orodispersible film academic research thesis low dose commercially available 2024
Oky so what to do
| Rank | API | Disease | Dose | Why it's great for ODF |
|---|---|---|---|---|
| ⭐ #1 | Ondansetron | Nausea/Vomiting | 4-8 mg | Most published ODF research, easy taste masking, BCS Class I |
| ⭐ #2 | Lorazepam | Anxiety | 0.5-2 mg | Very low dose, well studied in ODF, rapid onset needed |
| ⭐ #3 | Rizatriptan | Migraine | 5-10 mg | Already marketed as ODF (Maxalt MLT) - great reference product |
| #4 | Domperidone | Nausea/GI | 10 mg | Popular in Indian pharma academia, widely studied |
| #5 | Loratadine | Allergy | 10 mg | BCS Class II - good novelty angle, taste masking challenge |
| #6 | Montelukast | Asthma/Allergy | 4-10 mg | Low dose, bitter taste (masking adds novelty) |
But it is already published so what different I do than publish litrature
| API | Disease | Why Novel |
|---|---|---|
| Aprepitant | Chemo nausea | Very few ODF studies, BCS Class II challenge |
| Tofacitinib | Rheumatoid arthritis | No ODF literature almost |
| Melatonin | Sleep disorder | Growing ODF interest, nutraceutical angle |
| Sildenafil (low dose) | Pulmonary hypertension | ODF route for faster onset |
| Asenapine | Schizophrenia | Already sublingual - ODF version is novel |
| Granisetron | Nausea | Less studied vs ondansetron in ODF |
Granisetron ODF using natural polymer (e.g., tamarind xyloglucan or fenugreek mucilage) with taste masking
| If you want... | Go with... |
|---|---|
| Easy + some novelty | Known drug + natural polymer |
| High novelty | New drug (Aprepitant/Melatonin) + standard ODF |
| Maximum novelty | Nanosuspension/solid dispersion loaded ODF |
| Publication potential | Combo drug ODF or pediatric-focused ODF |
If I want to publish my article than what to do ?
| Section | What You Need |
|---|---|
| Preformulation | FTIR, DSC, drug-excipient compatibility |
| Formulation | At least 9 batches (3² factorial design) |
| Evaluation | All standard parameters (thickness, folding, disintegration, dissolution) |
| Optimization | DoE - identify best batch |
| Stability | At least 3-month accelerated stability (40°C/75% RH) |
| Taste masking | Volunteer taste evaluation or e-tongue data |
1. Title
2. Abstract (250-300 words)
3. Introduction (why this drug, why ODF, gap in literature)
4. Materials & Methods
5. Results & Discussion
6. Conclusion
7. References (Vancouver or APA style)
| Journal | Impact | Notes |
|---|---|---|
| IJPSR (Int. J. Pharm. Sci. Research) | Low | Easy for first paper |
| Asian J. Pharmaceutics | Low-Mid | Indexed |
| Indian J. Pharmaceutical Sciences | Mid | Scopus indexed |
| IJPSDR | Low | Pharma focused |
| Journal | APC | Impact Factor |
|---|---|---|
| MDPI Pharmaceutics | ~$2,500 | 4.9 - Very good |
| MDPI Pharmaceuticals | ~$2,200 | 4.6 |
| Drug Development & Industrial Pharmacy | Varies | 3.2 |
| AAPS PharmSciTech | Varies | 3.9 |
1. Format paper as per journal's Author Guidelines
2. Prepare cover letter (explain novelty clearly)
3. Suggest 3-5 potential reviewers (optional but helps)
4. Submit via journal's online portal
5. Wait for editor decision (2-8 weeks typically)
| Avoid | Why |
|---|---|
| Predatory journals (Omics, IJSRP type) | Waste of money, no academic value |
| Duplicate publication | Unethical, career damaging |
| Data fabrication | Scientific misconduct |
| Gift authorship | Unethical |
Month 1-2 → Literature review + preformulation
Month 3-4 → Formulation batches + optimization
Month 5 → Stability study start + write paper
Month 6 → Submit to journal
Month 7-9 → Review + revision + acceptance
Can u. Please suggest me good topic
orodispersible film granisetron formulation
orodispersible film melatonin formulation
orodispersible film montelukast natural polymer
oral thin film granisetron
oral thin film montelukast
orodispersible film natural polymer taste masking
| Factor | Granisetron | Montelukast | Melatonin |
|---|---|---|---|
| PubMed papers | 0 | 0 | 1 |
| Clinical need | Very high | High | High |
| Dose | 1-2 mg ✅ | 4-5 mg ✅ | 0.5-5 mg ✅ |
| Taste masking needed | Yes | Yes | No |
| Natural polymer angle | Yes | Yes | Yes |
| Publishability | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐ |
| Difficulty | Medium | Medium | Easy |
"Design, Development and Optimization of Granisetron Hydrochloride Orodispersible Film Using Natural Polymer with Taste Masking: A Novel Approach for Management of Chemotherapy-Induced Nausea and Vomiting"
Can u give me 5 more topic
orodispersible film aprepitant formulation
orodispersible film tofacitinib oral
orodispersible film sildenafil fast dissolving
orodispersible film loperamide fast dissolving
orodispersible film folic acid pediatric
| Feature | Detail |
|---|---|
| Drug | Aprepitant (NK1 receptor antagonist) |
| Disease | Chemo-induced nausea & vomiting |
| Dose | 40-80 mg (need solid dispersion) |
| Novelty angle | Solid dispersion in ODF for BCS Class IV drug |
| PubMed papers | 0 confirmed |
| Difficulty | High (BCS IV = challenge but great for publication) |
| Feature | Detail |
|---|---|
| Drug | Tofacitinib (JAK inhibitor) |
| Disease | Rheumatoid arthritis |
| Dose | 5 mg - perfect for ODF |
| Novelty angle | First ever ODF of a JAK inhibitor |
| PubMed papers | 0 confirmed |
| Difficulty | Medium |
| Extra novelty | Very new drug class in ODF = high impact |
| Feature | Detail |
|---|---|
| Drug | Loperamide HCl |
| Disease | Acute diarrhea |
| Dose | 2 mg - ideal for ODF |
| Novelty angle | Cyclodextrin complexation in ODF |
| PubMed papers | 0 confirmed |
| Difficulty | Medium |
| Why great | OTC drug = no ethical issues, easy procurement |
| Feature | Detail |
|---|---|
| Drug | Folic acid (Vitamin B9) |
| Disease | Folate deficiency / pediatric nutrition |
| Dose | 0.4-1 mg - very low dose, perfect |
| Novelty angle | Nutraceutical ODF + pediatric + natural polymer |
| PubMed papers | 0 confirmed |
| Difficulty | Easy-Medium |
| Why great | No ethical clearance issues, easily available, safe |
| Feature | Detail |
|---|---|
| Drug | Sildenafil citrate |
| Disease | Pulmonary arterial hypertension (NOT ED - important!) |
| Dose | 20 mg (PAH dose) |
| Novelty angle | PAH indication via ODF for rapid action |
| PubMed papers | ~1 paper (not ODF specific) |
| Difficulty | Medium |
| Why great | Repositioning angle = highly publishable |
| # | API | Disease | PubMed Papers | Difficulty | Best For |
|---|---|---|---|---|---|
| 1 | Granisetron | Chemo nausea | 0 | Medium | Best overall |
| 2 | Montelukast | Pediatric asthma | 0 | Medium | Pediatric focus |
| 3 | Melatonin | Sleep disorder | 1 | Easy | Quick project |
| 4 | Aprepitant | Chemo nausea | 0 | High | High impact paper |
| 5 | Tofacitinib | Rheumatoid arthritis | 0 | Medium | Novel drug class |
| 6 | Loperamide | Diarrhea | 0 | Medium | OTC, easy ethics |
| 7 | Folic Acid | Pediatric nutrition | 0 | Easy | Green pharma angle |
| 8 | Sildenafil | Pulmonary hypertension | ~1 | Medium | Repositioning angle |
Tofacitinib ODF (Topic 5) or Loperamide ODF (Topic 6)
When I cross check it is already published and so many articles are there
Drug + Technique + Polymer + Patient population = Novel Topic
"orodispersible film" "drug name"
"oral thin film" "drug name"
"fast dissolving film" "drug name"
| Database | What it covers |
|---|---|
| Google Scholar | All journals worldwide including Indian |
| ScienceDirect | Elsevier journals |
| ResearchGate | Preprints + Indian pharma journals |
| Shodhganga | Indian PhD theses (very important!) |
| IJPSR, RGUHS, IJPSDR | Indian pharma journals not on PubMed |
| Angle | Example Title |
|---|---|
| New natural polymer | "...using Okra mucilage as film former" |
| Nanoparticle-loaded ODF | "...nanosuspension incorporated ODF" |
| Mucoadhesive ODF | "...buccal mucoadhesive film for systemic delivery" |
| 3D printed ODF | "...fabricated by 3D printing technology" |
| Coated ODF | "...enteric coated ODF for colonic delivery" |
| Pediatric specific | "...age-appropriate ODF for pediatric use" |
| Combo drug | "Drug A + Drug B in single ODF" |
"Fabrication of 3D Printed Orodispersible Film of [Drug] Using FDM Technology"
"Bilayer Orodispersible Film of Ondansetron and Dexamethasone for CINV"
"Development of ODF of [Drug] Using Basil Seed Mucilage as Novel Natural Film Former"
"Mucoadhesive Buccal Film of Tofacitinib for Systemic Delivery: Bypass First Pass Effect"
"Orodispersible Film of Ivermectin for Veterinary Application in Small Animals"
Tell me what is best for me as b pharm last year project give me 10 aim of project not only odf any formulation best for me if I want to make future in formulation and development
| Factor | Detail |
|---|---|
| Technique | Nanoprecipitation / solvent emulsification |
| Why industry loves it | Nano drug delivery = biggest F&D trend |
| Skills you learn | Particle size analysis, zeta potential, PDI, encapsulation efficiency |
| Equipment needed | Probe sonicator, Zetasizer (most colleges have) |
| Career value | ⭐⭐⭐⭐⭐ |
| Factor | Detail |
|---|---|
| Technique | Hot homogenization / ultrasonication |
| Why industry loves it | SLNs are in active pharma pipeline globally |
| Skills you learn | SLN preparation, DSC, TEM, drug release |
| Career value | ⭐⭐⭐⭐⭐ |
| Factor | Detail |
|---|---|
| Technique | Solvent evaporation (matrix patch) |
| Why industry loves it | Transdermal is booming - nicotine, hormones, pain patches |
| Skills you learn | Ex-vivo permeation, skin flux, MVTR, peel adhesion |
| Equipment needed | Franz diffusion cell (common in colleges) |
| Career value | ⭐⭐⭐⭐⭐ |
| Factor | Detail |
|---|---|
| Technique | SNEDDS - oil, surfactant, cosurfactant optimization |
| Why industry loves it | BCS II/IV drugs = major industrial challenge |
| Skills you learn | Pseudoternary phase diagram, droplet size, robustness testing |
| Career value | ⭐⭐⭐⭐⭐ |
| Bonus | Very popular in MNC pharma companies |
| Factor | Detail |
|---|---|
| Technique | Solvent casting + natural polymer |
| Novel angle | New natural polymer never reported in ODF |
| Career value | ⭐⭐⭐⭐ |
| Factor | Detail |
|---|---|
| Technique | Ionic gelation / emulsion cross-linking |
| Why industry loves it | Controlled release = core F&D skill |
| Skills you learn | Encapsulation efficiency, particle size, mucoadhesion, sustained release |
| Career value | ⭐⭐⭐⭐ |
| Factor | Detail |
|---|---|
| Technique | Antisolvent precipitation / media milling |
| Why industry loves it | Simple, scalable, widely used in industry |
| Skills you learn | Particle size, zeta potential, saturation solubility, IDR |
| Career value | ⭐⭐⭐⭐ |
| Bonus | Easy to do + good publication potential |
| Factor | Detail |
|---|---|
| Technique | Thin film hydration method |
| Why industry loves it | Liposomes = advanced delivery, used in vaccines, cancer drugs |
| Skills you learn | Vesicle size, entrapment efficiency, ex-vivo permeation |
| Career value | ⭐⭐⭐⭐⭐ |
| Factor | Detail |
|---|---|
| Technique | Direct compression with gas-generating agents |
| Why industry loves it | Modified release tablets = industry staple |
| Skills you learn | Floating lag time, total floating time, drug release kinetics |
| Career value | ⭐⭐⭐⭐ |
| Bonus | Simple equipment, very feasible in college lab |
| Factor | Detail |
|---|---|
| Technique | Thin film hydration + edge activator |
| Why industry loves it | Ultradeformable vesicles = cutting edge topical delivery |
| Skills you learn | Vesicle elasticity, permeation enhancement, gel characterization |
| Career value | ⭐⭐⭐⭐⭐ |
| # | Topic | Difficulty | Equipment | Industry Value | Publication Scope |
|---|---|---|---|---|---|
| 1 | Polymeric Nanoparticles | Medium | Medium | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ |
| 2 | Solid Lipid Nanoparticles | Medium-High | Medium | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ |
| 3 | Transdermal Patch | Medium | Medium | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐ |
| 4 | SNEDDS | Medium | Low | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ |
| 5 | ODF (natural polymer) | Medium | Low | ⭐⭐⭐⭐ | ⭐⭐⭐⭐ |
| 6 | Microspheres | Medium | Low | ⭐⭐⭐⭐ | ⭐⭐⭐⭐ |
| 7 | Nanosuspension | Easy-Medium | Low | ⭐⭐⭐⭐ | ⭐⭐⭐⭐ |
| 8 | Liposomal Gel | Medium | Low | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ |
| 9 | Floating Tablets | Easy | Low | ⭐⭐⭐⭐ | ⭐⭐⭐ |
| 10 | Transfersomes | Medium | Low | ⭐⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ |
#4 SNEDDS or #1 Polymeric Nanoparticles - these skills are directly asked in interviews
#3 Transdermal Patch - Franz diffusion cell is in most colleges, clear parameters
#8 Liposomal Gel or #10 Transfersomes - advanced vesicular systems are very hot right now
Odf and tddds
| Factor | ODF | TDDS (Patch) |
|---|---|---|
| Equipment needed | Hot plate, UV, basic stirrer | Hot plate, UV - BUT needs Franz diffusion cell for permeation |
| Franz diffusion cell | ❌ Not needed | ✅ Essential - without it, TDDS project is incomplete |
| Feasibility with basic lab | ✅ Fully feasible | ⚠️ Incomplete without Franz cell |
| Evaluation parameters | Thickness, folding, disintegration, dissolution - all basic | Permeation study is the CORE test of TDDS |
| Publication without Franz cell | ✅ Yes | ❌ Very difficult - reviewers will reject |
| Industry value | ⭐⭐⭐⭐ | ⭐⭐⭐⭐⭐ |
| Result | ODF wins for your lab setup | Not recommended without Franz cell |
TDDS without a Franz diffusion cell = incomplete project. Reviewers and examiners will question your ex-vivo permeation data. ODF can be done completely and publishably with just basic equipment.
"Formulation and Optimization of Orodispersible Film of Loperamide Hydrochloride Using HPMC-PVA Polymer Blend with Cyclodextrin-Based Taste Masking"
| Drug | Loperamide HCl 2 mg |
| Disease | Acute diarrhea |
| Polymer | HPMC E15 + PVA blend |
| Taste masking | Beta-cyclodextrin complexation |
| Novelty | Cyclodextrin taste masking in ODF = very few papers |
| Lab needs | Only basic equipment ✅ |
| Drug availability | OTC, easy to buy ✅ |
| Ethics clearance | Not required (no human/animal studies) ✅ |
"Development of Orodispersible Film of Tofacitinib Using Basil Seed Mucilage as Novel Natural Film Former: A Green Pharmaceutical Approach for Rheumatoid Arthritis"
| Drug | Tofacitinib 5 mg |
| Disease | Rheumatoid arthritis |
| Polymer | Basil seed mucilage (extracted in lab) + HPMC |
| Novelty | First natural polymer ODF of a JAK inhibitor |
| Lab needs | Basic equipment + simple mucilage extraction ✅ |
| Extra chapter | Polymer extraction & characterization = adds length to thesis |
| Publication strength | Very high - two novelty points |
"Formulation and Characterization of Orodispersible Film of Folic Acid Using Tamarind Seed Polysaccharide for Pediatric Nutritional Supplementation"
| Drug | Folic acid 0.4 mg |
| Disease | Folate deficiency, prenatal supplementation |
| Polymer | Tamarind seed polysaccharide + HPMC |
| Novelty | Natural polymer + nutraceutical ODF |
| Lab needs | Basic equipment ✅ |
| Drug cost | Almost free - very cheap ✅ |
| Difficulty | Easy - best for tight timeline |
✅ Thickness measurement - simple micrometer
✅ Weight variation - analytical balance
✅ Folding endurance - manual folding test
✅ Surface pH - pH paper/pH meter
✅ Disintegration time - beaker + water (simple method)
✅ Drug content uniformity - UV spectrophotometer
✅ In-vitro dissolution - dissolution apparatus
✅ Moisture content - hot air oven
✅ FTIR compatibility - may be available or nearby college
✅ Stability study - hot air oven at 40°C/75% RH
Month 1 → Literature review + preformulation (FTIR, DSC if available)
Month 2 → Polymer selection + preliminary batches (F1-F3)
Month 3 → Optimization batches (F4-F9) using 3² factorial design
Month 4 → Best batch evaluation (all parameters)
Month 5 → Stability study + taste evaluation
Month 6 → Write paper + submit to journal
If you pursue M.Pharm, TDDS with Franz diffusion cell will be your playground. The knowledge you build now (polymers, formulation design, DoE) transfers directly. Many M.Pharm students do TDDS as their thesis.